Similar articles

• [Nuclear oncology 2000: the end of individualized professionalism].

  Carrio I. Carrio I. Rev Esp Med Nucl. 2000 Jun;19(3):179-81. Rev Esp Med Nucl. 2000. PMID: 11062079 Spanish. No abstract available.
• Radiopharmaceutical research and production in Brazil: a 30-year history of participation in the nuclear medicine scenario.

  Santos-Oliveira R, Antunes LJ. Santos-Oliveira R, et al. J Nucl Med Technol. 2011 Sep;39(3):237-9. doi: 10.2967/jnmt.111.088450. Epub 2011 Jul 27. J Nucl Med Technol. 2011. PMID: 21795367
• Guidelines--child's play or a practical minefield?

  [No authors listed] [No authors listed] Nucl Med Commun. 2007 Jul;28(7):583. doi: 10.1097/01.mnm.0000251335.45525.d7. Nucl Med Commun. 2007. PMID: 17538401 No abstract available.
• Emerging technologies in radiation oncology and nuclear medicine: an overview of their use and regulation.

  Foens C. Foens C. J Am Coll Radiol. 2004 Sep;1(9):619-23. doi: 10.1016/j.jacr.2004.05.002. J Am Coll Radiol. 2004. PMID: 17411667 Review. No abstract available.
• [Future prospects for nuclear medicine].

  Senda K, Tonami N. Senda K, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 1995 Oct;55(13):508-16. Nihon Igaku Hoshasen Gakkai Zasshi. 1995. PMID: 8721345 Review. Japanese.